Source:http://linkedlifedata.com/resource/pubmed/id/16257223
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-2-28
|
pubmed:abstractText |
The transforming growth factor-betas (TGF-betas) regulate the induction of dopaminergic neurons and are elevated in the CSF of Parkinson's patients. We report here that mice with TGF-beta2 haploinsufficiency (TGF-beta2+/-) have subclinical defects in the dopaminergic neurons of their substantia nigra pars compacta. At 6 weeks of age, the TGF-beta2+/- mice had 12% fewer dopaminergic neurons than wild-type littermates. No additional loss of neurons occurred during the next 5 months, although striatal dopamine declined to 70% of normal. The level of 3,4-dihydroxphenylacetic acid was normal in the TGF-beta2+/- mice, indicating that a compensatory mechanism maintains dopamine stimulation of their striatum. The TGF-beta2+/- mice had normal sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, despite having reduced levels of monoamine oxidase-B. These results raise the possibility that people with naturally low levels of TGF-beta2 may have less functional reserve in their nigrostriatal pathway, causing them to be at increased risk of developing Parkinson disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0969-9961
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
568-75
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16257223-Age Factors,
pubmed-meshheading:16257223-Animals,
pubmed-meshheading:16257223-Cell Count,
pubmed-meshheading:16257223-Dopamine,
pubmed-meshheading:16257223-Haplotypes,
pubmed-meshheading:16257223-Immunohistochemistry,
pubmed-meshheading:16257223-MPTP Poisoning,
pubmed-meshheading:16257223-Mice,
pubmed-meshheading:16257223-Neurons,
pubmed-meshheading:16257223-Polymerase Chain Reaction,
pubmed-meshheading:16257223-RNA, Messenger,
pubmed-meshheading:16257223-Substantia Nigra,
pubmed-meshheading:16257223-Transforming Growth Factor beta,
pubmed-meshheading:16257223-Transforming Growth Factor beta2
|
pubmed:year |
2006
|
pubmed:articleTitle |
Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits.
|
pubmed:affiliation |
Neuromuscular Research Group, Department of Anatomy and Structural Biology, School of Medical Sciences, University of Otago, P.O. Box 913, Dunedin, New Zealand.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|